Category: Technology Licenses
Created On: 2022-04-28
Record Count: 10
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 195625
A septum, which is a thin wall of muscle or tissue which divides two or more chambers of the heart or other anatomic spaces of the human body, sometimes is perforated by an abnormal aperture passing through the septum, described as a septal defect. When septal defects occur between adjacent chambers of the heart or its associated major blood vessels, blood can leak from one chamber or artery to another imposing added strain on the heart which may lead to heart failure. An opening in the abdominal wall may allow bowel to pass through it, causing a hernia.
The surgical repair of intracardiac defects has required the use of open chest surgical techniques wherein the defect is directly sutured shut.
IPSCIO Record ID: 4808
IPSCIO Record ID: 5941
The Licensee has an exclusive worldwide License from the Licensor under United States patents entitled Occluder and Method for Repair of Cardiac and Vascular Defects (U.S. Patent No. 5,425,744), Occluder for Repair of Cardiac and Vascular Defects (U.S. Patent No. 5,451,235) and Self-Centering Umbrella-Type Septal Closure Device (U.S. Patent No. 5,709,707) and the respective corresponding foreign patents, patent applications and associated know-how.
IPSCIO Record ID: 28651
(a) In the United States, application No. 09/733,224 entitled Annuloplasty System, filed December 8, 2000;
(b) In Canada, application No. 2,197,069 entitled Apparatus for Reducing the Circumference of a Vascular Structure, filed August 10, 1995;
(c) In the European Region, application No. 95929486.9 entitled Apparatus for Reducing the Circumference of a Vascular Structure, filed August 10, 1995; and
(d) In Japan, application No. 507532/1996 entitled Apparatus for Reducing Circumference of Vascular Structure, filed August 10, 1995 and any and all patents and/or patent applications claiming priority thereto, and any and all patents or patent applications in which either Segmed or Dr. Northrup is an inventor, which relate to the Device and/or any apparatus and/or method for reducing, sizing and/or stabilizing the circumference of a vascular or anatomical structure, and any reissues, continuations, divisions, continuations-in-part or extensions thereof, any patents issuing therefrom; and/or any improvements thereto or enhancements thereof which are either wholly or in part owned, invented, controlled, acquired or otherwise assignable by either or both of the Assignors, and any patent applications therefor and any patents issuing therefrom.
â€œDeviceâ€ shall mean the apparatus and/or method for reducing, sizing and/or stabilizing the circumference of a vascular or anatomical structure (the â€œFieldâ€) covered by the Intellectual Property and fully described in the Applications and applications relating to the Patents, and any and all improvements, modifications, derivations, enhancements, technology, Know-how and Documentation related thereto.
Patent relates to a new annuloplasty technology for the repair of mitral and tricuspid heart valves.
â€œPatentsâ€ shall mean the following patents issued to Assignors in the United States, Australia, Taiwan and South Africa
(a) In the United States, U.S. Patent No. 5,593,424 entitled Apparatus and Method for Reducing and Stabilizing the Circumference of a Vascular Structure, issued January 14, 1997, U.S. Patent No. 5,709,695 entitled Apparatus for Reducing the Circumference of a Vascular Structure, issued January 20, 1998, and U.S. Patent No. 5,961,539 entitled Method and Apparatus for Sizing, Stabilizing and/or Reducing the Circumference of an Anatomical Structure, issued October 5, 1999;
(b) In Australia, patent No. 700530 entitled Apparatus for Reducing Circumference of Vascular Structure, filed August 10, 1995;
(c) In Taiwan, patent No. 096871 entitled Apparatus for Reducing the Circumference of a Bodily Structure, filed August 11, 1995; and
(d) In South Africa patent No. 95/6672 entitled Apparatus and Method for Reducing the Circumference of a Vascular Structure, filed August 10, 1995,
and any and all patents and/or patent applications claiming priority thereto, and any and all patents or patent applications in which Assignors are an inventor, which relate to the Device and/or any apparatus or method for reducing, sizing and/or stabilizing the circumference of a vascular or anatomical structure, and any reissues, continuations, divisions, continuations-in-part or extensions thereof, any patents issuing therefrom, and/or any improvements thereto or enhancements thereof which are either wholly or in part owned, invented, controlled, acquired or otherwise assignable by Assignors, and any patent applications therefor and any patents issuing therefrom.
â€œTrademarkâ€ shall mean the mark represented by United States Registration No. 2,108,883 for the â€œSEGMENTâ€ mark.
IPSCIO Record ID: 2357
A. Soft Tissue Includes Gore patch products used in the following applications
i) Reconstruction of hernias and soft tissue deficiencies, such as abdominal wall defects, diaphragmatic hernia, laparoscopic hernia, pelvic floor and lid reconstruction, ventral hernia, laparoscopic inguinal hernia, muscle flap reconstruction, vaginal prolapse, rectal prolapse, scrotal hernia, gastric banding and temporary facial bridging; and
ii) Plastic and reconstructive surgery, such as malarplasty, mentoplasty, rhinoplasty, maxilloplasty, frontal defects, reconstructive lip augmentations, orbital repair, facial folds, facial slings and auricuoplasty.
B. Cardiovascular Includes Gore patch products used in cardiovascular and cardiac patching, such as carotid patch, angioplasty, profundaplasty, AV access graft patching, septal defects, outflow tracts, aneurysm repair and other patch angioplasty.
C. Surgical Membrane/Adhesion Limiting Includes Gore patch products used in the following applications
i) Reconstruction or repair of the peritoneum, where minimal adhesions to a prosthetic material are desired, such as infertility surgery, gynecological surgery and gynecological and surgical oncology;
ii) Temporary or permanent prosthesis for the repair of dura mater during neurosurgery, such as tumor resection, tethered cord releases, trauma repair and Chiari decompression;
iii) Reconstruction of the pericardium where minimal adhesions are desired; and
iv) Wrap for pedicled arterial conduits.
IPSCIO Record ID: 27403
IPSCIO Record ID: 6158
Patent ductus arteriosus (PDA) is a congenital disorder in the heart wherein a neonate's ductus arteriosus fails to close after birth.
IPSCIO Record ID: 294278
Licensor Patents means a Patent that (a) claims the Product or any component thereof, or any other method, apparatus, material or article of manufacture useful in the development, manufacture, use or sale of Product, and (b) is Controlled by Licensor.
Product means the PFO Closure Device developed under this Agreement and described in the Device Description and Sequence of Operation as set forth. The PFO closure device is intended to close a heart abnormality – the patent foreman ovale (PFO).
Patent means (a) unexpired United States and foreign patents, including without limitation any substitution, extension, registration, confirmation, reissue, re-examination, renewal of such patents and (b) pending applications for such patents, including without limitation any continuation, divisional or continuation-in-part thereof and any provisional applications.
A PFO closure device is moved through the vein to the heart, and specifically to the location of the heart wall defect. Once in the correct location, the PFO closure device is formed so that it straddles each side of the hole. The device will remain in the heart permanently to stop the abnormal flow of blood between the two atrial chambers of the heart. The catheter is then removed and the procedure is complete.
IPSCIO Record ID: 299236
This agreement is extending Licenseeâ€™s worldwide right and license to use, manufacture, have manufactured, distribute and sell, and to grant sublicenses to its Affiliates to use, manufacture, have manufactured, distribute and sell, the Licensor Technology in the Peripheral Vascular Field of Use and the GI Field of Use.
Licensor newly grants its licensee, the right for Licensee to have third party Distributors distribute Eligible Peripheral Vascular and/or GI Products.
This agreement is co-exclusive with an option to become exclusive.
The license agreement regards paclitaxel-eluting stent products and related technologies. Paclitaxel is released from the balloon or stent to prevent scar tissue formation in the blood vessel that can re-obstruct the artery (restenosis).
As used herein, the Peripheral Vascular Field of Use means the endoluminal vascular licensed applications for the treatment or preventionof disease of the peripheral blood vessels of the body. Notwithstanding the foregoing, Peripheral Vascular Field of Use excludes any application in the Coronary Vascular Field of Use.
GI Field of Use means the endoluminal licensed applications for the treatment or prevention of disease of the alimentary tract or liver.
IPSCIO Record ID: 310350
Licensor is a medical device company, with products including cardiac devices, cranial and spine robotics, insulin pumps, surgical tools, and patient monitoring systems.
This agreement is for the technology, patent and applications are for Catheter Mapping System and Application, including, specifically, U.S Patent No 5,697,377, and all trade secrets and know-how owned by Licensor prior to the date of this Agreement which relate specifically and directly to 3-D electrode localization devices and techniques as disclosed in the patents or patent applications, including but not necessarily limited to software developed specifically to practice the inventions disclosed in the patents included in the Licensed Technology, and new patents arising out of patent applications filed, or inventions reduced to practice and relate specifically and directly to 3-D electrode localization devices and techniques.
Licensee is engaged in the development of the EnSite diagnostic catheter and clinical workstation for use by electrophysiologists in diagnosing and mapping abnormal heart rhythms known as tachycardias.